567 related articles for article (PubMed ID: 15112095)
1. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
[TBL] [Abstract][Full Text] [Related]
3. Health care provision in pediatric rheumatology in Germany--national rheumatologic database.
Minden K; Niewerth M; Listing J; Zink A;
J Rheumatol; 2002 Mar; 29(3):622-8. PubMed ID: 11908581
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
[TBL] [Abstract][Full Text] [Related]
6. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
7. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
8. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
9. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
10. [Personal experience with methotrexate in the treatment of idiopathic juvenile arthritis].
Tambić-Bukovac L; Malcić I; Prohić A
Reumatizam; 2002; 49(1):20-4. PubMed ID: 12476749
[TBL] [Abstract][Full Text] [Related]
11. Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis.
Dueckers G; Guellac N; Arbogast M; Dannecker G; Foeldvari I; Frosch M; Ganser G; Heiligenhaus A; Horneff G; Illhardt A; Kopp I; Krauspe R; Markus B; Michels H; Schneider M; Singendonk W; Sitter H; Spamer M; Wagner N; Niehues T
Clin Immunol; 2012 Feb; 142(2):176-93. PubMed ID: 22154868
[TBL] [Abstract][Full Text] [Related]
12. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
13. [Evidence and consensus based treatment guidelines 2010 for juvenile idiopathic arthritis by the German Society of Paediatric Rheumatology].
Dueckers G; Guellac N; Arbogast M; Dannecker G; Foeldvari I; Frosch M; Ganser G; Heiligenhaus A; Horneff G; Illhardt A; Krauspe R; Markus B; Michels H; Schneider M; Singendonk W; Sitter H; Spamer M; Wagner N; Niehues T;
Klin Padiatr; 2011 Nov; 223(6):386-94. PubMed ID: 22012606
[TBL] [Abstract][Full Text] [Related]
14. The German etanercept registry for treatment of juvenile idiopathic arthritis.
Horneff G; Schmeling H; Biedermann T; Foeldvari I; Ganser G; Girschick HJ; Hospach T; Huppertz HI; Keitzer R; Küster RM; Michels H; Moebius D; Rogalski B; Thon A;
Ann Rheum Dis; 2004 Dec; 63(12):1638-44. PubMed ID: 15115709
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
16. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
17. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
18. [Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis].
Canhão H; Santos MJ; Costa L; Bogas M; Mourão AF; Machado P; Fonseca JE; Silva JA;
Acta Reumatol Port; 2009; 34(1):78-95. PubMed ID: 19377402
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
Borte S; Liebert UG; Borte M; Sack U
Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
[TBL] [Abstract][Full Text] [Related]
20. [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis].
Santos MJ; Fonseca JE; Canhão H; Conde M; José Vieira M; Costa L; Costa M; Salgado M; Melo Gomes JA;
Acta Reumatol Port; 2007; 32(1):43-7. PubMed ID: 17450764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
